Dabigatran Antidote Praxbind Picks Up Full FDA Approval Dabigatran Antidote Praxbind Picks Up Full FDA Approval
Granted accelerated approval in 2015, the company now has received full FDA approval for idarucizumab to reverse the effects of dabigatran.FDA Approvals
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Cardiology News Alert Source Type: news